Lee JS - Search Results

1

Lazertinib Versus Gefitinib Tyrosine Kinase Inhibitors in Treatment-Naíve Patients With EGFR-Mutated Advanced NSCLC: Analysis of the Asian Subpopulation in LASER301.

Reungwetwattana T, Cho BC, Lee KH, Pang YK, Fong CH, Kang JH, Lee YG, Lim CS, Danchaivijitr P, Lim YN, Lee Y, How SH, Geater S, Lee SS, Min YJ, Kim JH, Lee JS, Lee GW, Soo RA, Lee SY, Choi S, Ahn MJ. Reungwetwattana T, et al. Among authors: lee sy, lee y, lee js, lee kh, lee yg, lee ss, lee gw. J Thorac Oncol. 2023 Oct;18(10):1351-1361. doi: 10.1016/j.jtho.2023.06.016. Epub 2023 Sep 11. J Thorac Oncol. 2023. PMID: 37702629 Free article. Clinical Trial.

2

High-dose versus low-dose cyclophosphamide in combination with G-CSF for peripheral blood progenitor cell mobilization.

Ahn JS, Park S, Im SA, Yoon SS, Lee JS, Kim BK, Bang SM, Cho EK, Lee JH, Jung CW, Kim HC, Seong CM, Lee MH, Kim CS, Lee KS, Lee JA, Ahn MJ. Ahn JS, et al. Among authors: lee ja, lee js, lee ks, lee mh, lee jh. Korean J Intern Med. 2005 Sep;20(3):224-31. doi: 10.3904/kjim.2005.20.3.224. Korean J Intern Med. 2005. PMID: 16295781 Free PMC article. Clinical Trial.

3

Combination chemotherapy with gemcitabine and cisplatin as first-line treatment for immunohistochemically proven cholangiocarcinoma.

Lee GW, Kang JH, Kim HG, Lee JS, Lee JS, Jang JS. Lee GW, et al. Among authors: lee js. Am J Clin Oncol. 2006 Apr;29(2):127-31. doi: 10.1097/01.coc.0000203742.22828.bb. Am J Clin Oncol. 2006. PMID: 16601429 Clinical Trial.

4

Combination chemotherapy with irinotecan and cisplatin in elderly patients (>or= 65 years) with extensive-disease small-cell lung cancer.

Kim HG, Lee GW, Kang JH, Kang MH, Hwang IG, Kim SH, Hahm JR, Jeong YY, Kim HC, Lee JD, Lee JS, Hwang YS. Kim HG, et al. Among authors: lee js, lee jd, lee gw. Lung Cancer. 2008 Aug;61(2):220-6. doi: 10.1016/j.lungcan.2007.12.020. Epub 2008 Feb 12. Lung Cancer. 2008. PMID: 18272249 Clinical Trial.

5

Fixed-dose rate infusion of gemcitabine and weekly cisplatin in elderly or poor performance status patients with unresectable non-small cell lung cancer.

Lee GW, Kang MH, Kim HG, Kang JH, Kim SH, Cho YJ, Jeong YY, Kim HC, Lee JD, Hwang YS, Kim HJ, Lee JS. Lee GW, et al. Among authors: lee js, lee jd. Cancer Chemother Pharmacol. 2009 Jul;64(2):385-90. doi: 10.1007/s00280-008-0885-5. Epub 2008 Dec 23. Cancer Chemother Pharmacol. 2009. PMID: 19104817

6

A phase II trial of haptaplatin/5-FU and leucovorin for advanced stomach cancer.

Lee WS, Lee GW, Kim HW, Lee OJ, Lee YJ, Ko GH, Lee JS, Jang JS, Ha WS. Lee WS, et al. Among authors: lee js, lee oj, lee yj, lee gw. Cancer Res Treat. 2005 Aug;37(4):208-11. doi: 10.4143/crt.2005.37.4.208. Epub 2005 Aug 31. Cancer Res Treat. 2005. PMID: 19956515 Free PMC article.

7

Randomized Phase III trial of gefitinib versus docetaxel in non-small cell lung cancer patients who have previously received platinum-based chemotherapy.

Lee DH, Park K, Kim JH, Lee JS, Shin SW, Kang JH, Ahn MJ, Ahn JS, Suh C, Kim SW. Lee DH, et al. Among authors: lee js. Clin Cancer Res. 2010 Feb 15;16(4):1307-14. doi: 10.1158/1078-0432.CCR-09-1903. Epub 2010 Feb 9. Clin Cancer Res. 2010. PMID: 20145166 Clinical Trial.

8

A phase II trial of docetaxel and ifosfamide for patients with platinum-resistant or refractory non-small cell lung cancer in a salvage setting.

Lee GW, Kang JH, Kim SH, Lee HY, Kim HC, Lee WS, Lee JD, Hwang YS, Jang JS, Lee JS. Lee GW, et al. Among authors: lee js, lee jd, lee ws, lee hy. Cancer Res Treat. 2004 Oct;36(5):287-92. doi: 10.4143/crt.2004.36.5.287. Epub 2004 Oct 31. Cancer Res Treat. 2004. PMID: 20368817 Free PMC article.

9

A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutations.

Kim DW, Lee SH, Lee JS, Lee MA, Kang JH, Kim SY, Shin SW, Kim HK, Heo DS. Kim DW, et al. Among authors: lee sh, lee ma, lee js. Lung Cancer. 2011 Jan;71(1):65-9. doi: 10.1016/j.lungcan.2010.04.005. Lung Cancer. 2011. PMID: 20430469 Clinical Trial.

10

Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: a combined clinical-molecular pathological approach.

Salto-Tellez M, Tsao MS, Shih JY, Thongprasert S, Lu S, Chang GC, Au JS, Chou TY, Lee JS, Shi YK, Radzi A, Kang JH, Kim SW, Tan SY, Yang JC. Salto-Tellez M, et al. Among authors: lee js. J Thorac Oncol. 2011 Oct;6(10):1663-9. doi: 10.1097/JTO.0b013e318227816a. J Thorac Oncol. 2011. PMID: 21869714 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,367 results

Search Page